Table 5 Adverse events during on-demand therapy (safety analysis set).

From: Assessment of the efficacy of on-demand tegoprazan therapy in gastroesophageal reflux disease through a randomized controlled trial

 

Tegoprazan 50 mg

(n = 37)

Esomeprazole 20 mg

(n = 35)

p-value*

N (%)

[F]

N (%)

[F]

Total adverse events

0 (0.00)

[0]

5 (14.29)

[6]

0.0232

Grade of adverse events

Mild

0 (0.00)

[0]

5 (14.29)

[6]

0.0232

Moderate

-

-

-

-

 

Severe

-

-

-

-

 

Serious AEs

-

-

-

-

 

Drug-related AEs

-

-

-

-

-

Deaths

-

-

-

-

 
  1. AE adverse events, [F] Frequency of AEs.
  2. *Fisher’s Exact test.
Back to article page